Back to Investors
BG

BlueLion Global

Venture Capital

Portfolio

1

companies


Portfolio companies

Emm

Emm

Emm develops biowearable technology designed to provide actionable insights into menstrual health.


Recent investments

Seed
£6.8M

The financing round was led by Lunar Ventures to support product commercialisation and clinical development.

"Menstruation is known as the fifth vital sign, but has historically been overlooked by the wearable sector, leaving millions without the data they need to understand and advocate for their own bodies. We envision a future where menstrual health is measured and understood as comprehensively as cardiovascular or metabolic health, giving people access to objective, actionable insights to better manage their health and wellbeing."
— Jenny Button, Founder and CEO